Status:

UNKNOWN

High Flow Nasal Cannula in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) HF-study

Lead Sponsor:

Hospital Clinic of Barcelona

Conditions:

Patient Population Submitted to ERCP

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The expected results with this study are that high flow devices (LAF) provide adequate respiratory support during the performance of ERCP under deep sedation, reducing episodes of desaturation, hypove...

Detailed Description

Deep sedation performed during the ERCP technique associates an increased risk of decrease in Sat02%, hypercapnia and airway obstruction with consequences ranging from interruption or suspension of th...

Eligibility Criteria

Inclusion

  • Patients Age over ≥18 years. Willing to participate

Exclusion

  • None

Key Trial Info

Start Date :

February 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2021

Estimated Enrollment :

172 Patients enrolled

Trial Details

Trial ID

NCT04082208

Start Date

February 1 2020

End Date

January 1 2021

Last Update

February 11 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinic Hospital (Endoscopy Unit)

Barcelona, Spain, 08036

High Flow Nasal Cannula in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) HF-study | DecenTrialz